表 1.
EGFR野生型和突变型肺腺癌患者的相关临床资料分析
Analysis of clinical data of patients with EGFR-mutation and EGFR-wild lung adenocarcinoma
| Characteristic | EGFR | P | ||
| Mutation (n=67) | Wild (n=434) | |||
| Missing values exsit in The Cancer Genome Atlas. The percentages of the mutant group in the table are all calculated with 67 as the denominator; the percentages of the wild group in the table are all calculated with 434 as the denominator. EGFR: epidermal growth factor receptor. | ||||
| Gender | Male | 19 (28%) | 213 (49%) | 0.003 |
| Female | 48 (72%) | 221 (51%) | ||
| Age (yr) | < 60 | 18 (27%) | 116 (27%) | 0.942 |
| ≥60 | 46 (67%) | 303 (70%) | ||
| Smoking status | Ever | 39 (58%) | 368 (85%) | < 0.001 |
| Never | 24 (36%) | 43 (10%) | ||
| T stage | T1/T2 | 57 (85%) | 380 (88%) | 0.505 |
| T3/T4 | 10 (15%) | 52 (12%) | ||
| N stage | N0 | 36 (54%) | 285 (66%) | 0.069 |
| N1/N2/N3 | 29 (43%) | 141 (32%) | ||
| M stage | M0 | 45 (67%) | 292 (67%) | 0.847 |
| M1 | 3 (4%) | 22 (5%) | ||
| Stage | Ⅰ/Ⅱ | 48 (72%) | 343 (79%) | 0.151 |
| Ⅲ/Ⅳ | 19 (28%) | 89 (21%) | ||